Company Snapshot

Funding Stage
Pre-seed
Key Business
A peptide drug conjugate (PDC) discovery platform focused on novel drug modalities for precision therapies, primarily targeting cancer and CNS disorders
Key Deliverables
Two PCCs for cancers and one for Alzheimer's Disease
Background
A spin-off from the University of California, Davis
Technology Founders
The inventor and leader of OBOC and combinatorial chemistry technology
Business Leaders
Founders of multiple startup companies and R&D leaders from multinational pharmaceutical companies

Contact Us

Shawn Mu: shawnmu02@yahoo.com

Steve Mason: steve.mason295@gmail.com

Focus on Innovation & Exploration

Innovation is at the heart of everything we do. Our journey of discovery is just beginning.

Explore Our Peptide Discovery Platforms Partner With Us